COVID-19 vaccine was invalid. But the court ruled another similar patent was valid and that Pfizer and BioNTech's Comirnaty vaccine had infringed it, meaning Moderna is entitled to damages in relation to
Jan 15 (Reuters) - Gilead Sciences (GILD.O) and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday
The decision stems from a dispute between patent owner Mitsui Chemicals and opponent Borealis over EP 2 626 911, which protects solar cell sealing material and a solar cell module. Opposition
Myers Squibb is behind the plaintiff. Johnson & Johnson is now challenging the patent at the UK High Court with a revocation action. The patent-in-suit is also under fire at the European Patent
American manufacturing company 3M has settled a patent infringement dispute with Saint-Gobain Abrasives. Saint-Gobain Abrasives allegedly infringed several of 3M’s European patents. The allegedly